Epilepsy and Seizure News
Neurofeedback News
Can Neurofeedback Effectively Treat ADHD? -
Neurofeedback training is an alternative therapy that uses real-time EEG data to help patients train their brains to improve focus, impulse control, and executive function. Since the 1970s, patients ...
Rewiring Your Brain: Neurofeedback Goes Mainstream -
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Will Strahl walked up to my door with a massive black briefcase in his ...
Can Monitoring Brain Waves Boost Mental Health? -
Neurofeedback has promised a mental health revolution for decades. But is it effective? Credit...Tony Luong for The New York Times Supported by By David Dodge Twice a week, Stephanie, a 37-year-old ...
Novel neurofeedback technique enhances awareness of mind-wandering -
Everyone knows the feeling. You are trying to concentrate on driving or studying, or paying attention in a boring meeting, but suddenly, you realize that you are thinking about something irrelevant to ...
What Does a Neurofeedback Technician Do? -
Neurofeedback is about helping a client's brain learn to self-regulate by showing it its own EEG activity on a screen or through headphones. It is like going to the gym for your brain. It is not a ...
Medical News Today
PubMed
Seizure Recurrence and Long-Term Outcomes After a Second Antiseizure Medication Withdrawal Attempt in Patients with Epilepsy: A Retrospective Cohort Study -
CONCLUSION: Recurrence was common after a second ASM withdrawal attempt in this small, predominantly pediatric-onset cohort, but most patients who relapsed later regained seizure control. Female sex was associated with recurrence, whereas no independent association was detected for either the inter-withdrawal interval or the seizure-free duration before the second attempt. These findings are ex...
Sappanone A suppresses CHOP expression and exerts neuroprotective effects in epilepsy -
CONCLUSION: Our findings suggest that SA pretreatment exerts neuroprotective effects against epilepsy, potentially through suppression of CHOP expression. However, the causal relationship between CHOP suppression and SA-mediated neuroprotection in epilepsy warrants further investigation.
Astrocytes at the interface of peri-ictal breathing dysfunction and SUDEP -
Sudden unexpected death in epilepsy (SUDEP) is the leading cause of epilepsy-related mortality and is typically characterized by a terminal cascade of respiratory failure, cardiac arrhythmia, and cerebral suppression. Although epilepsy has long been regarded as a neuron-proprietary disorder, accumulating evidence indicates that glial cells, particularly astrocytes, play pivotal roles in both ep...
Multimodal modeling of the ictal onset zone in refractory insular epilepsy and seizure outcome of magnetic resonance-guided laser interstitial therapy: A pediatric single-center retrospective study -
OBJECTIVE: This study was undertaken to evaluate seizure outcomes after magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) in children with insular epilepsy and to assess how the extent of ablation overlaps with multimodal definitions of the ictal onset zone (IOZ).
Positioning Cenobamate in the Treatment Algorithm of Focal Epilepsy: Seizure Control and Benefits Beyond Seizures -
This work integrates the opinion on the current use of cenobamate (CNB) of an expert panel structured across seven thematic domains: efficacy, patient profiles, titration and dosing, pharmacokinetic interactions, safety, parallel effects, and therapeutic positioning. According to personal experience and scientific evidence, experts unanimously regarded CNB as likely more efficacious than other ...
Efficacy of Lactobacillus reuteri as an adjunctive therapy for seizure control and quality of life in pediatric drug-resistant epilepsy: A prospective interventional study -
CONCLUSIONS: In this single-arm before-after study, statistically significant within-participant changes in HRQOL and seizure frequency were observed during the 12-week period following adjunctive L. reuteri supplementation. However, the absolute magnitude of these changes was modest and their clinical significance remains uncertain. Because there was no concurrent placebo control group, the ob...
Science Daily